News

09 March 2016

ulbrich&partner launches cooperation with SmartStep

SmartStep is a consulting firm specialized in the field of health care.

 [MORE]

The firm provides market access consultation and other services related to health care with a focus on market access consulting for pharmaceutical and medical device companies. It also initiates, implements, accompanies and evaluates all measures that are used to translate its market access consulting solutions into practice.

To the SmartStep homepage

16 November 2015

Healthcare Shapers Network collaboration

Dr. Claudia Ulbrich becomes member of Healthcare Shapers.

 [MORE]

24 September 2015

Gentherapie 4.0 am Kapitalmarkt

Wie weit ist man mit Gentherapien heute? 2012 hat die EMA mit Glybera das erste Gentherapeutikum zugelassen.

 [MORE]

Der Gentherapie-Markt erfährt nach erheblichen Rückschlägen in der Vergangenheit einen starken Aufwärtstrend. Lesen Sie mehr in der neuen Going Public Ausgabe auf

Seite 54-65 von Dr. Claudia Ulbrich

20 July 2015

Science4Life Venture Cup 2015 - Final Competition

ulbrich&partner coached team aquila biolabs.

 [MORE]

12 July 2015

BMS and uniQure Success-Story

BMS and uniQure closed the biggest genetherapy deal so far ulbrich&partner acted as business advisor.

 [MORE]

30 June 2015

ulbrich&partner event schedule: 3. Forum Digital Transition

Meet ulbrich&partner at 3. Forum Digital Transition – Innovationstreiber im Gesundheitswesen, 8 July 2015, Munich.

 [MORE]

07 June 2015

ulbrich&partner event schedule: Family Day 2015

ulbrich&partner participates in Family Day Hightech Gründerfonds, 23/24 June 2015 in Bonn.

 [MORE]

02 June 2015

ulbrich&partner event schedule: Bio America 2015

Meet ulbrich&parter at BIO America, 14-18 June 2015 in Philadelphia, USA.

 [MORE]

10 May 2015

ulbrich&partner event schedule: Bioequity 2015

ulbrich&partner present at Bioequity, 19/20 May 2015 in Vienna

 [MORE]

01 May 2015

ulbrich&partner event schedule: Digital Health Day 2015

ulbrich&partner attends Digital Health Day, 7 May 2015, Berlin

 [MORE]
Page 2 of 2 Previous
Schliessen

Impressum

ulbrich&partner management consulting
Claudia Ulbrich MD
Güntherstraße 7A | 30519 Hannover | Germany | Mobile +49 (0) 172 / 455 76 32
Phone +49 (0) 511 / 37 48 40 51
info@ulbrichpartner.com
Geschäftsführung: Dr. Claudia Ulbrich

1. Content
The author reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. All offers are not-binding and without obligation. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement.

2. Referrals and links
The author is not responsible for any contents linked or referred to from his pages - unless he has full knowledge of illegal contents and would be able to prevent the visitors of his site from viewing those pages. If any damage occurs by the use of information presented there, only the author of the respective pages might be liable, not the one who has linked to these pages. Furthermore the author is not liable for any postings or messages published by users of discussion boards, guestbooks or mailing lists provided on his page.

3. Copyright
The author intended not to use any copyrighted material for the publication or, if not possible, to indicate the copyright of the respective object. The copyright for any material created by the author is reserved. Any duplication or use of objects such as images, diagrams, sounds or texts in other electronic or printed publications is not permitted without the author's agreement.

4. Privacy policy
If the opportunity for the input of personal or business data (email addresses, name, addresses) is given, the input of these data takes place voluntarily. The use and payment of all offered services are permitted - if and so far technically possible and reasonable - without specification of any personal data or under specification of anonymized data or an alias. The use of published postal addresses, telephone or fax numbers and email addresses for marketing purposes is prohibited, offenders sending unwanted spam messages will be punished.

5. Legal validity of this disclaimer
This disclaimer is to be regarded as part of the internet publication which you were referred from. If sections or individual terms of this statement are not legal or correct, the content or validity of the other parts remain uninfluenced by this fact.

Schliessen